NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 199 filers reported holding NEKTAR THERAPEUTICS in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,558,000 | +60.3% | 90,704 | +2.2% | 0.20% | -24.4% |
| Q3 2015 | $972,000 | -19.4% | 88,717 | -19.1% | 0.27% | -38.6% |
| Q1 2015 | $1,206,000 | +581.4% | 109,612 | +859.8% | 0.43% | +365.6% |
| Q4 2014 | $177,000 | -23.7% | 11,420 | -36.8% | 0.09% | +43.1% |
| Q2 2014 | $232,000 | +48.7% | 18,062 | +31.7% | 0.06% | +124.1% |
| Q4 2013 | $156,000 | -81.6% | 13,710 | -83.1% | 0.03% | -84.7% |
| Q3 2013 | $846,000 | – | 81,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |